A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. [electronic resource]
Producer: 20160308Description: 2025-37 p. digitalISSN:- 1740-634X
- Adolescent
- Adult
- Aged
- Anti-Anxiety Agents -- therapeutic use
- Cognition Disorders -- etiology
- Depressive Disorder, Major -- complications
- Dose-Response Relationship, Drug
- Double-Blind Method
- Duloxetine Hydrochloride -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neuropsychological Tests
- Piperazines -- therapeutic use
- Psychiatric Status Rating Scales
- Sulfides -- therapeutic use
- Surveys and Questionnaires
- Treatment Outcome
- Vortioxetine
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.